Literature DB >> 7977457

XLPRA: a canine retinal degeneration inherited as an X-linked trait.

G M Acland1, S H Blanton, B Hershfield, G D Aguirre.   

Abstract

Breeding studies are reported of a previously undescribed hereditary retinal degeneration identified in the Siberian Husky breed of dog. This disorder clinically resembles the previously reported autosomal recessive canine hereditary retinal degenerations collectively termed progressive retinal atrophy (PRA). However, the pedigree of the propositus, a male Siberian Husky, exhibited an X-linked pattern of transmission. This dog was outcrossed to three phenotypically normal female laboratory Beagles and two of their F1 daughters were bred to a phenotypically normal male Beagle, producing affected males in the F2 generation. Subsequent inbreedings produced further affected males and affected females as well. X-linked transmission was established by exclusion of alternative modes of inheritance and, consequently, the disease has been termed X-linked progressive retinal atrophy (XLPRA). This is the first reported X-linked retinal degeneration in an animal. Because of the many similarities of PRA in dogs to retinitis pigmentosa (RP) in humans, this new disease may not only represent the first animal model of X-linked RP (XLRP) but may well be a true homolog of one of the XLRP loci (RP2, RP3, RP6). It is the first retinal degeneration in dogs that can be assigned to an identified canine chromosome, and the first for which linkage mapping offers a realistic approach to proceed by positional cloning towards identifying the responsible gene locus.

Entities:  

Mesh:

Year:  1994        PMID: 7977457     DOI: 10.1002/ajmg.1320520106

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  15 in total

Review 1.  Semper fidelis: what man's best friend can teach us about human biology and disease.

Authors:  E A Ostrander; E Giniger
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 2.  Genetic and phenotypic variations of inherited retinal diseases in dogs: the power of within- and across-breed studies.

Authors:  Keiko Miyadera; Gregory M Acland; Gustavo D Aguirre
Journal:  Mamm Genome       Date:  2011-11-08       Impact factor: 2.957

3.  Diagnostic ophthalmology.

Authors:  B Grahn; J Wolfer
Journal:  Can Vet J       Date:  1995-11       Impact factor: 1.008

4.  Inherited retinal diseases in dogs: advances in gene/mutation discovery.

Authors:  Keiko Miyadera
Journal:  Dobutsu Iden Ikushu Kenkyu       Date:  2014

5.  Linkage analysis and comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology with retinitis pigmentosa (RP17) in humans.

Authors:  G M Acland; K Ray; C S Mellersh; W Gu; A A Langston; J Rine; E A Ostrander; G D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  A large deletion in RPGR causes XLPRA in Weimaraner dogs.

Authors:  Regina Kropatsch; Denis A Akkad; Matthias Frank; Carsten Rosenhagen; Janine Altmüller; Peter Nürnberg; Jörg T Epplen; Gabriele Dekomien
Journal:  Canine Genet Epidemiol       Date:  2016-07-08

7.  Analysis of six candidate genes as potential modifiers of disease expression in canine XLPRA1, a model for human X-linked retinitis pigmentosa 3.

Authors:  Richard Guyon; Susan E Pearce-Kelling; Caroline J Zeiss; Gregory M Acland; Gustavo D Aguirre
Journal:  Mol Vis       Date:  2007-07-11       Impact factor: 2.367

Review 8.  The genetics of eye disorders in the dog.

Authors:  Cathryn S Mellersh
Journal:  Canine Genet Epidemiol       Date:  2014-04-16

9.  Investigation of SLA4A3 as a candidate gene for human retinal disease.

Authors:  Louise M Downs; Andrew R Webster; Anthony T Moore; Michel Michaelides; Robin R Ali; Alison J Hardcastle; Cathryn S Mellersh
Journal:  J Negat Results Biomed       Date:  2016-05-23

10.  Molecular studies of phenotype variation in canine RPGR-XLPRA1.

Authors:  Tatyana Appelbaum; Doreen Becker; Evelyn Santana; Gustavo D Aguirre
Journal:  Mol Vis       Date:  2016-04-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.